Please Scroll Down to See Forums Below
Darts
- Thread starter Strongbow
- Start date
beachhead06
New member
Well, my friend uses 1.5" 22g for most anabolic androgenic steroids, and that is larger than the 25g you are talking about. My friend really doesn't understand what the problem with using a 25g is, 25g isn't that big... Plus if you were to drink the Winstrol - stanozolol you could save yourself a dart... 
Most Winstrol - stanozolol can be injected using 25, or 27g on the smaller size.
Most Winstrol - stanozolol can be injected using 25, or 27g on the smaller size.
Strongbow
New member
I keep hearing about drinking winstrol. Can u actually drink winstrol the injectable kind. Bet that tastes like shit, but it would save me some pain in the ass. What about your liver? I done injections because, injected winny doesn't make its first pass through the liver, that would naturally be out the window if i drank it, but ive been on milk thistle anyway, so whats the deal, is this a better way than the shots.beachhead06 said:Well, my friend uses 1.5" 22g for most anabolic androgenic steroids, and that is larger than the 25g you are talking about. My friend really doesn't understand what the problem with using a 25g is, 25g isn't that big... Plus if you were to drink the Winstrol - stanozolol you could save yourself a dart...
beachhead06
New member
Guardian, I read that in one of your previous posts that drinking winstrol can increase IGF-1, anymore info or studies on this?
Injection is better for nitrogen retention
"The effect of stanozolol on 15-nitrogen retention in the dog
Can J Vet Res 2000 Oct;64(4):246-8 (ISSN: 0830-9000)
Olson ME; Morck DW; Quinn KB [Find other articles with these Authors] Animal Health Unit and Gastrointestinal Sciences, University of Calgary, Alberta.
The objective of the study was to determine the influence of either oral or intramuscular administration of stanozolol on nitrogen retention in dogs by using a non-invasive 15N-amino acid tracer technique. Ten healthy, intact, adult male sled dogs received either stanozolol tablets, 2 mg/dog PO, q12h, for 25 days (Group 1, n = 5) or an intramuscular injection of 25 mg of stanozolol on Days 7, 14, 21, and 28 (Group 2, n = 5). A 15N amino acid (5.27 mmol) was infused intravenously into each dog on Day 0 (before stanozolol treatment) and on Day 31 (after stanozolol treatment). Urine was collected by catheterization from each animal 3 times daily for 3 consecutive days. The 15N-urea enrichment in urine was determined by high-resolution mass spectrometry and the total amount of urea in the urine was determined.
Both oral and injectable stanozolol resulted in significant (P < 0.05) increases in amino acid nitrogen retention compared to pretreatment values. Oral stanozolol increased nitrogen retention from 29.2 +/- 8.2% to 50.3 +/- 9.2%, while stanozolol injection increased nitrogen retention from 26.6 +/- 9.9% to 67.0 +/- 7.5%. The response to intramuscular administration was significantly greater than the response to the oral dosing regime. Stanozolol increases amino acid nitrogen retention in dogs, as has been previously observed in rats. This action of stanozolol may be beneficial in dogs under stress of surgical trauma and chronic disease."
This one is specifically for winstrol but for oral testosterone verus serum testosterone. I believe it has more to do with the fact that it is a 17aa steroid designed to make a first pass through the liver like dbol and anadrol. I think it has something do to with the stress being placed on the liver.
Maturitas, Volume 51, Issue 3, 16 July 2005, Pages 286-293
Comparison of effects of the rise in serum testosterone by raloxifene and oral testosterone on serum insulin-like growth factor-1 and insulin-like growth factor binding protein-3
"Abstract
Objective: In aging men serum levels of testosterone and insulin-like growth factor-1 (IGF-1) decline, potential factors in the reduced muscle strength, abdominal obesity, sexual dysfunction and impaired general well being of aging. The partial oestrogen agonist and antagonist raloxifene increase serum testosterone levels in aging men, but the effect of raloxifene on serum IGF-1 levels in men is unknown. In this study the effects of raloxifene on IGF-1 levels and the associated increase in serum testosterone were compared to the effects of oral testosterone supplementation.
Design and patients: Thirty healthy elderly men between 60 and 70 years received raloxifene 120 mg/day or placebo in a randomised double blind fashion for 3 months. Secondly, seven female to male (F to M) transsexuals undergoing hormonal sex reassignment received testosterone undecanoate 160 mg/day.
Measurement: At baseline and after three months serum levels of testosterone, IGF-1 and its most important binding protein, IFGBP-3 was measured. In the group transsexuals also serum gonadotrophins and 17β-oestradiol was measured.
Results: Compared to placebo raloxifene increased serum testosterone by 20% but it decreased serum IGF-1 levels by 24.5% (95% confidence interval (CI): −13.0 to −36.1%). No significant change in serum IGFBP-3 levels was found. The effect of raloxifene on serum IGF-1 has been observed with other oral oestrogens, and, therefore, is likely to be ascribed to the partial oestrogen agonist activity of raloxifene. In the F to M transsexuals, serum testosterone levels increased from median <1.0 nmol/l to 6.2 nmol/l, without significant changes in serum gonadotrophins and 17β-oestradiol levels. Serum IGF-1 levels increased by 12.1% (95% CI: 1.9–22.3%) versus baseline. No effect was observed on serum IGFBP-3 levels.
Conclusion: Both raloxifene and oral testosterone increased serum testosterone, but raloxifene significantly decreased serum IGF-1 levels without affecting IGFBP-3. By contrast, oral testosterone supplementation in F to M transsexuals increased IGF-1 levels. In both treatment groups no significant change in serum IGFBP-3 was found."
"The effect of stanozolol on 15-nitrogen retention in the dog
Can J Vet Res 2000 Oct;64(4):246-8 (ISSN: 0830-9000)
Olson ME; Morck DW; Quinn KB [Find other articles with these Authors] Animal Health Unit and Gastrointestinal Sciences, University of Calgary, Alberta.
The objective of the study was to determine the influence of either oral or intramuscular administration of stanozolol on nitrogen retention in dogs by using a non-invasive 15N-amino acid tracer technique. Ten healthy, intact, adult male sled dogs received either stanozolol tablets, 2 mg/dog PO, q12h, for 25 days (Group 1, n = 5) or an intramuscular injection of 25 mg of stanozolol on Days 7, 14, 21, and 28 (Group 2, n = 5). A 15N amino acid (5.27 mmol) was infused intravenously into each dog on Day 0 (before stanozolol treatment) and on Day 31 (after stanozolol treatment). Urine was collected by catheterization from each animal 3 times daily for 3 consecutive days. The 15N-urea enrichment in urine was determined by high-resolution mass spectrometry and the total amount of urea in the urine was determined.
Both oral and injectable stanozolol resulted in significant (P < 0.05) increases in amino acid nitrogen retention compared to pretreatment values. Oral stanozolol increased nitrogen retention from 29.2 +/- 8.2% to 50.3 +/- 9.2%, while stanozolol injection increased nitrogen retention from 26.6 +/- 9.9% to 67.0 +/- 7.5%. The response to intramuscular administration was significantly greater than the response to the oral dosing regime. Stanozolol increases amino acid nitrogen retention in dogs, as has been previously observed in rats. This action of stanozolol may be beneficial in dogs under stress of surgical trauma and chronic disease."
This one is specifically for winstrol but for oral testosterone verus serum testosterone. I believe it has more to do with the fact that it is a 17aa steroid designed to make a first pass through the liver like dbol and anadrol. I think it has something do to with the stress being placed on the liver.
Maturitas, Volume 51, Issue 3, 16 July 2005, Pages 286-293
Comparison of effects of the rise in serum testosterone by raloxifene and oral testosterone on serum insulin-like growth factor-1 and insulin-like growth factor binding protein-3
"Abstract
Objective: In aging men serum levels of testosterone and insulin-like growth factor-1 (IGF-1) decline, potential factors in the reduced muscle strength, abdominal obesity, sexual dysfunction and impaired general well being of aging. The partial oestrogen agonist and antagonist raloxifene increase serum testosterone levels in aging men, but the effect of raloxifene on serum IGF-1 levels in men is unknown. In this study the effects of raloxifene on IGF-1 levels and the associated increase in serum testosterone were compared to the effects of oral testosterone supplementation.
Design and patients: Thirty healthy elderly men between 60 and 70 years received raloxifene 120 mg/day or placebo in a randomised double blind fashion for 3 months. Secondly, seven female to male (F to M) transsexuals undergoing hormonal sex reassignment received testosterone undecanoate 160 mg/day.
Measurement: At baseline and after three months serum levels of testosterone, IGF-1 and its most important binding protein, IFGBP-3 was measured. In the group transsexuals also serum gonadotrophins and 17β-oestradiol was measured.
Results: Compared to placebo raloxifene increased serum testosterone by 20% but it decreased serum IGF-1 levels by 24.5% (95% confidence interval (CI): −13.0 to −36.1%). No significant change in serum IGFBP-3 levels was found. The effect of raloxifene on serum IGF-1 has been observed with other oral oestrogens, and, therefore, is likely to be ascribed to the partial oestrogen agonist activity of raloxifene. In the F to M transsexuals, serum testosterone levels increased from median <1.0 nmol/l to 6.2 nmol/l, without significant changes in serum gonadotrophins and 17β-oestradiol levels. Serum IGF-1 levels increased by 12.1% (95% CI: 1.9–22.3%) versus baseline. No effect was observed on serum IGFBP-3 levels.
Conclusion: Both raloxifene and oral testosterone increased serum testosterone, but raloxifene significantly decreased serum IGF-1 levels without affecting IGFBP-3. By contrast, oral testosterone supplementation in F to M transsexuals increased IGF-1 levels. In both treatment groups no significant change in serum IGFBP-3 was found."
Nice find , G .^^^^^^^
Brad.
Brad.
02gixxersix
New member
Exactly how I feel. I get way more discomfort from 25g's because it takes so long and the needle has more time to move around. 23g 1in is the way to go.sweed said:
A
ALIN
Guest
Strongbow said:
AAS need to be injected deep IM
builtbychevy
New member
hahaha i use 18 1.5" and 21 1.5"... dont be a poosy
Similar threads
